We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Novel Mouthguard Monitors Health Markers

By HospiMedica International staff writers
Posted on 23 Sep 2015
A new mouthguard can monitor uric acid in the saliva and transmit the information wirelessly to a smart phone, laptop, or tablet.

Developed at the University of California, San Diego (UCSD; USA), the mouthguard monitor uses printed sensor technology based on silver, Prussian blue ink and uricase, an enzyme that reacts specifically with uric acid. More...
Because human saliva is an extremely complex viscous liquid that contains many different biomarkers, the researchers set up the chemical equivalent of a two-step authentication system to make sure that the sensors only reacted with the uric acid. Similar sensors are also being developed for lactate and cortisol.

The first step is a series of chemical keyholes, which ensures that only the smallest biochemicals get inside the sensor. The second step is a layer of uricase trapped in polymers, which reacts selectively with uric acid. The reaction between acid and enzyme generates hydrogen peroxide (H2O2), which is detected by the Prussian blue ink. That information is then transmitted to an electronic board which that senses the output of the sensors, digitizes the output, and then wirelessly transmits data to a smart phone, tablet or laptop.

The researchers conducted a study using saliva samples from healthy volunteers and spread them on the sensor, which produced readings in a normal range. Next, they collected saliva from a patient who suffers from hyperuricemia, a condition characterized by an excess of uric acid in the blood; the sensor detected more than four times as much uric acid in the patient's saliva than in the healthy volunteers. When the patient took Allopurinol, they were able to document a drop in uric acid levels over four or five days as the medication took effect. The study was published in the September 2015 issue of Biosensors and Bioelectronics.

“The ability to monitor continuously and noninvasively saliva biomarkers holds considerable promise for many biomedical and fitness applications,” said lead author Professor of nano-engineering Joseph Wang, PhD, of the Center for Wearable Sensors at UCSD. “It could be used in the future to monitor hospitalized patients continuously without the need for invasive procedures, monitor athletes' performance, or study stress levels in soldiers and pilots.”

Related Links:

University of California, San Diego



Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Open Stapler
PROXIMATE Linear Cutter
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.